Covid Vaccine Nanobot Detection Method Developed — Study

study recently posted on social media by BeyondBio CEO John Catanzaro and reposted by Dr. Peter McCullough detailed research into a novel detection method for the nanotechnology within the exotic Covid injections.

“In summary, we have demonstrated simple and efficient plasmonic-magnetic nanorobot-based SARS-CoV-2 RNA detection assay,” the study said in the ‘Conclusion’ section.

The researchers began by explaining how the novel pandemic led to exotic technology injections.

“The coronavirus disease 2019 (COVID‐19) has prompted an urgent demand for nanotechnological solutions towards the global healthcare crisis, particularly in the field of diagnostics, vaccines, and therapeutics. As an emerging tool for nanoscience and technology, micro/nanorobots have demonstrated advanced performances, such as self-propelling, precise maneuverability, and remote actuation, thus hold great potential to provide breakthroughs in the COVID-19 pandemic,” the study said in the ‘Abstract’ section.

They then went into their detection method for this exotic technology.

“Here we show a plasmonic-magnetic nanorobot-based simple and efficient COVID-19 detection assay through an electronic readout signal. The nanorobots consist of Fe3O4 [iron oxide] backbone and the outer surface of Ag [silver], that rationally designed to perform magnetic-powered propulsion and navigation, concomitantly the probe nucleic acids transport and release upon the hybridization which can be quantified with the differential pulse voltammetry (DPV) technique,” the study said in the ‘Abstract’ section.

Nanorobots, also called nanobots (a form of nanotechnology) are defined by the researchers.

Keep reading

Pfizer BioNTech COVID19 Solution Builds Mesogen Microchips When Left At Room Temperature. Exactly What We See In COVID Unvaccinated Blood From Shedding. Two Week Follow Up

I have shown extensive research on mesogen microchips that have self assembled in COVID19 unvaccinated blood. My work was built on Toxicologist Dr. Hildegard Staningers research on mesogen brain chips found in Targeted Individuals, published in 2012.

GLOBAL BRAIN CHIP AND MESOGENS Nano Machines for Ultimate Control of False Memories – Computer System For Collective Mind Control

Are Programmable Nanotechnology Biosensing Mesogen “Computer Chip” Devices Being Self Assembled In C19 Uninjected Blood ? How Dangerous Is Self Spreading Nanotechnology?

Nano Robot Swarm Self Assembly Of Nanotechnology Mesogen in C19 Unvaccinated Blood – Darkfield Live Blood Analysis

Darkfield Live Blood Microscopy Of A Discoid Mesogen Self Assembly Nanotechnology Device In C19 Unvaccinated Blood

Here is further video footage in the Pfizer BioNTech COVID19 Injection solution after 2 weeks left on room temperature on a slide. Ongoing nano and microrobotic swarming seen and in the center the outline of a mesogen is seen. This contains many microrobots and usually a polymer background.

Keep reading

Part 2 of the results of the Swedish bad batch analysis that confirms the Danish study – 3/4 of adverse events in Sweden were amongst women

Not so fun fact: 75% of Swedish adverse events were reported on behalf of women.

Not a single Danish newspaper is publishing these results. The research was crowd funded, instead of being compiled by government agencies – these agencies could give a rat’s hairy ass!

From this 18-minute video here.

Swedish pfizer side effects (youtube.com)

https://onlinelibrary.wiley.com/doi/1… Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and Sweden https://pubmed.ncbi.nlm.nih.gov/39202… 2023, Nationwide study from Denmark Identified a batch-dependent safety signal for the BNT162b2 mRNA COVID-19 vaccine 2024, Suspected adverse events (SAEs) Denmark and Sweden SAEs reported to national authorities”

Keep reading

Sudden ‘Unexpected’ Infant Death Increased Post-Covid Shot Rollout — Study

study published Thursday documented how sudden unexpected infant death (SUID) and sudden infant death syndrome (SIDS) increased slightly during the Covid pandemic of 2020, after which a massive increase was documented following the Covid exotic technology injection rollout in 2021.

“In this cross-sectional study of 14,308 SUID cases, the risk of SUID and SIDS increased during the intrapandemic period (March 2020 to December 2021) compared with the prepandemic period (March 2018 to December 2019), with the greatest increases noted in 2021 (9% for SUID and 10% for SIDS). A marked statistically significant monthly increase in SUID from June to December 2021 was observed,” the study said in the ‘Findings’ section.

While there was an uptick in infant deaths beginning in July 2020, between June 2021 and December 2021 there was a massive increase of up to 14 percent. Notably, the lethal Covid injections generally rolled out around the start of 2021.

“Monthly assessments revealed an increased risk of SUID beyond the prepandemic baseline starting in July 2020, with a pronounced epidemiologic shift from June to December 2021 (ranging from 10% to 14%),” the study said in the ‘Results’ section.

The researchers defined these deadly syndromes as umbrella terms for dead babies. It should also be noted that there is now ‘post Covid vaccine syndrome‘.

“Sudden unexpected infant death is an umbrella term used to describe the sudden death of an infant younger than 1 year for whom the cause of death is not apparent prior to investigation. Deaths from sudden infant death syndrome (SIDS), which occur during sleep and remain unexplained after a thorough postmortem investigation, comprise more than one-third of SUID cases,” the study said in the ‘Introduction’ section.

Ironically, the researchers bypassed the elephant in the room and claimed that the cause of the 2021 increase came down to ‘altered infectious disease transmission’.

Keep reading

Journal Pressured to Retract Study on Covid-19 Vaccine Harms

Avaccine manufacturer based in India launched defamation proceedings against researchers who published a study that reported adverse events in people following Covid-19 vaccination.  

The manufacturer also sued the editor of the international journal that published the study and demanded that the offending article be retracted immediately.

The Peer-Reviewed Study

The study at the centre of the controversy is a post-marketing safety analysis (phase IV) of Covaxin, one of India’s homegrown Covid-19 vaccines.

The researchers concluded that serious adverse events of special interest (AESI) after vaccination “might not be uncommon” and that the majority of AESIs in people persisted “for a significant period.”

Of the 635 participants involved, one-third reported developing AESIs such as new-onset skin disorders, nervous system disorders, and menstrual and ocular abnormalities.

Serious AESI, such as stroke and Guillain-Barre syndrome, were experienced by 1% of participants, but no causal link could be established in the study.

The researchers called for “enhanced awareness and larger studies” to carefully examine the potential for long-term harms of the vaccine.

The study was published in the journal Drug Safety on May 13, 2024, after it was examined by two independent peer-reviewers and the editor of the journal.

Keep reading

Response To Critics Of Lee & Broudy (2024) On The Toxicity And Self-Assembling Technology In Incubated Samples Of Injectable mRNA Materials

Our article “Real-Time Self-Assembly . . . ” (Lee & Broudy, 2024) published in this journal has attracted attention from scholars, commentators, and professional fact-checkers from around the world, most of it featuring generous praise and some of it impassioned pleas for its authors to stick to their own areas of expertise. Our reply to the critics of this study is an attempt to address and accommodate scholarly critique and answer other concerns about our perceived lack of know-how to engage in such research. In this response, we suggest that a reflexive and singular focus on the declared components of the COVID injectables represents a bias of its own, and a lack of due diligence on our critics’ part. The “Nano– Bio–Info–Cogno (NBIC)” era of the 21st century (see Jamali et al., 2018) is an already very well-documented development (Cevallos et al., 2022; The White House, 2022), and our aim is to urge scholars to enlarge the critical lens they use to assess these phenomena. This broadening of perspective has direct bearing on science and scholarship, direct implications for the status of legacy biosciences, and requires inclusion in any explanatory framework, which we discuss briefly in this reply.

Introduction

Professor Ian Akyildiz, pioneer of the Internet of Bio-Nano Things (IoBNT), pointed out in an advanced technology symposium in 2023:

… the Bio-nanoscale machines [behind the IoBNT] are for injecting into the body … and that is going really well with these Covid vaccines. It’s going that direction. These mRNAs are nothing [other] than small scale, nano-scale machines. They are programmed, and they are injected [Akyildiz, 2023; also see Akyildiz et al., 2015].

In the article, “Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructions in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitudinal Study”, Lee and Broudy (2024) described the results of an observational and exploratory study of 54 samples of COVID injectable products, viewed under a stereomicroscope. The samples were incubated for up to 630 days and observed for both morphology and behavior.

Various self-assembling structures were found to form over time, some of which showed responsiveness to conditions of incubation, including a marked acceleration in development upon exposure to wireless radiation. In the context of relevant scholarly discussions in the diverse fields of interest, we noted that, “our observations suggest the presence of some kind of nanotechnology in the COVID-19 injectables” (in our abstract on p. 1180). We added that, “both the morphology and behavioral characteristics of these observed phenomena suggest that far from being pure (Finn, 2011 p. 138), these injectables are composed of, hitherto, undisclosed additional engineered components responsive to a range of internal and ambient forms of energy, all of which are traceable to and described throughout the scholarly literature” (p. 1229).

Reactions to the incubation study after publication have been offered by scholars and interested observers — some productive, others not. We are sincerely grateful to Professor Anne Ulrich (2024) for offering her thoughtful and detailed perspective on our efforts and, thus, confine our response to her analysis. As a professional of 35 years in the pharmaceutical industry and professor of organic chemistry, Ulrich has taken time to offer an alternate interpretation of our findings. We are heartened to see she takes no issue with the methods, noting that, “the experiments were carried out diligently and the resulting images are well documented” (p. 1244.7). Ulrich also agrees that the structures we observed to develop over time were formed from self-assembling nanoparticles.

The point of departure between our two interpretations concerns the nature of the nanoparticles from which the incubated structures formed. We proposed that the self-assembling components may be consistent with nanotechnologies relevant to the Internet of Bodies. Ulrich, in contrast argues that they arise from lipid nanoparticles and cholesterol ingredients in the modRNA injectable platforms. Absent compositional analysis, which is forthcoming, neither interpretation can be decisively ruled in or out based solely upon the observational data obtained to date. We remain open to disconfirmation should compositional analysis support Ulrich’s interpretation over ours. However, we maintain that our interpretation fits the extant observational data and appears consistent with the much wider range of relevant scholarly literature and research.

Keep reading

Robert Kadlec, Project Bioshield and mpox vaccines

In 2022, an outbreak of mpox (formerly known as monkeypox) garnered global attention, leading to a public health emergency declaration by the WHO.

In 2023, a new variant of the virus emerged, resulting in over 21,000 reported cases by August 2024. WHO declared the epidemic a public health emergency of international concern in August 2024.

The Project BioShield Act of 2004 aimed to defend against bioterrorism by accelerating the research and availability of medical countermeasures. This led to the development of Jynneos, the first approved monkeypox vaccine developed by Bavarian Nordic.

A second smallpox vaccine, ACAM2000, was approved for use against mpox by the US Food and Drug Administration last month.  This second vaccine is manufactured by the controversial Emergent BioSolutions.

Among ACAM2000 horrifying adverse effects is that the live vaccinia virus, which the vaccine contains, can be transmitted to persons who have close contact with the vaccinee causing the same horrific adverse effects, including death.

How could ACAM2000 have gotten approval in the first place?  Former US Assistant Secretary of Health and Human Services (Preparedness and Response) Robert Kadlec and his connections might provide the answer.

Keep reading

Shocking CDC Revelation: COVID Vaccine Linked to 24-Year Lifespan Reduction – Is Your Health at Risk?

The long-term consequences of Covid-19 vaccination are now being realised…

Over a year ago, double vaccinated Australians were 10.72x more likely to catch Omicron than the unvaxxed. Now they are 20x more likely and the triply or more vaxxed are 35x more likely, as the latest NSW Health stats show (see below).

Meanwhile, the latest Cleveland Clinic Data and the latest US data analysed by Josh Stirling, founder of Insurance Collaboration to Save Livess and former #1 ranked Insurance Analyst, shows a really really disturbing trend.

The damage to health caused by each vaccine dose does not lessen over time. It continues indefinitely

In fact, CDC All-Cause Mortality data show that each vaccine dose increased mortality by 7% in the year 2022 compared to the mortality in year 2021.

So if you have had 5 doses then you were 35% more likely to die in 2022 than you were in 2021. If you have had one dose then you were 7% more likely to die in 2022 than you were in 2021. If you are unvaxxed then you were no more likely to die in 2022 than you were in 2021.

Keep reading

Bombshell Court Order: FDA Admits Graphene Oxide Found in Pfizer mRNA Vaccines – Confidential Docs Exposed!

The Covid-19 vaccines have been at the centre of a heated debate since their introduction, with many questions and concerns raised about their safety and effectiveness.

Speculation has also been rife that the Covid-19 injections may contain traces of Graphene Oxide, a highly toxic and conductive substance.

Medicine regulators, with the support of the Mainstream Media, have repeatedly denied these claims.

But they were lying to you.

Because recent evidence has emerged that confirms the presence of Graphene Oxide, a highly toxic and conductive substance, in the Pfizer vaccine. And it has come from the US Food and Drug Administration (FDA) which has been forced to publish the confidential Pfizer documents by order of the Federal Court in the USA.

Keep reading

Japan’s Emergency Press Conference Highlights Urgent Concerns About mRNA Replicon Vaccine Approval

On September 12, 2024, Japanese Member of Parliament Ryuhei Kawada led a highly charged emergency press conference in Japan, voicing deep skepticism about the country’s upcoming launch of mRNA replicon vaccines, or what some call self-amplifying mRNA vaccines. The event set off alarm bells among critics of government policies, accusing authorities of prioritizing pharmaceutical profits over public health.

What are mRNA Replicon Vaccines?

As you know, mRNA COVID vaccines, like those developed by Pfizer and Moderna for COVID-19, use a small piece of genetic code (mRNA) to instruct your cells to produce a piece of the virus known as the spike protein.

On the other hand, self-amplifying mRNA vaccines, or replicon vaccines, represent a more advanced version where the mRNA not only instructs your cells to produce the spike protein but also makes copies of itself (yay! more mRNA…) once inside the cells.

ARCT-154, scheduled to be administered to the population in October 2024, is a self-amplifying mRNA COVID-19 vaccine from the dynamic duo of Arcturus Therapeutics and Duke-NUS Medical School in Singapore. In Japan, Arcturus Therapeutics found an ally in CSL Seqirus for crafting and distributing their vaccines through a local pharma company called Meiji Seika Pharma.

Arcturus Therapeutics is a biotech company located in San Diego, California, established in 2013. Just like Moderna, which didn’t release any products to the market until their mRNA experimental COVID vaccine, Arcturus also hasn’t launched any medical products yet, and their self-amplifying mRNA vaccine will be their first.

Arcturus was formed through a merger with Alcobra Pharma, an Israeli pharmaceutical company, after Alcobra faced difficulties during clinical trials, which led to their merger with Arcturus Therapeutics in 2017. Interestingly, Alcobra translates to “The Cobra.” You have to wonder who decided that naming their pharma company after a snake was a good idea. At this point, my eyes are rolling all the way to the back of my head, so I will stop talking about the company’s history here.

Keep reading